A Clinical Analysis of Extrapulmonary Complications in Novel Coronavirus Pneumonia Patients
Authors Sun BW, Zhang M, Wang PC, Song JT
Received 25 November 2020
Accepted for publication 6 January 2021
Published 9 February 2021 Volume 2021:14 Pages 381—385
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Bo-Wen Sun,1,* Min Zhang,1,* Ping-Chao Wang,2 Jiang-Tao Song3
1Department of Respiratory Medicine, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150036, People’s Republic of China; 2Department of Critical Care Medicine, People’s Hospital of Hanchuan, Hanchuan, 431600, People’s Republic of China; 3Department of Orthopedics, People’s Hospital of Hanchuan, Hanchuan, 431600, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Ping-Chao Wang
Department of Critical Care Medicine, People’s Hospital of Hanchuan, No. 1 Of Peoples Avenue, Hanchuan, 431600, People’s Republic of China
Department of Orthopedics, People’s Hospital of Hanchuan, No. 1 Of Peoples Avenue, Hanchuan, 431600, People’s Republic of China
Objective: This study aimed to investigate the clinical manifestation and treatment effects of extrapulmonary complications in cases of novel coronavirus pneumonia.
Methods: The clinical data of patients with novel coronavirus pneumonia who were admitted to Hanchuan People’s Hospital between January and March 2020 were retrospectively analyzed, and the clinical characteristics, laboratory test results, and treatment pathways of patients with extrapulmonary complications were analyzed and summarized.
Results: Of the 500 patients in this study, 97 patients with a history of chronic diseases were excluded, and 152 patients had extrapulmonary complications. Common extrapulmonary syndromes: 98 patients (64.47%) suffered from digestive system involvement; 43 patients (28.29%) suffered from cardiovascular system damage; 32 patients (21.05%) had urinary system damage; 25 patients (16.45%) had nervous system damage; and 30 patients (19.74%) had more than two kinds of system damage. In all cases, these patients were treated with comprehensive measures, and effective outcomes were achieved.
Conclusion: According to the clinical characteristics and laboratory test results of this sample group, early evaluation of patients with extrapulmonary complications and timely symptomatic treatment can effectively improve outcomes of pneumonia treatment, accelerate the alleviation of symptoms, and improve patients’ condition.
Keywords: novel coronavirus pneumonia, clinical characteristics, laboratory test, extrapulmonary complications, curative effect
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]